(Q24306987)

GOA release 2020-03-11

1 reference

12

0 references

Thorsten Stiewe

object named as

Thorsten Stiewe

13

0 references

Peter Friedl

object named as

Peter Friedl

9

0 references

Markus Sauer

object named as

Markus Sauer

6

0 references

author name string

Hakan Cam

1

0 references

Heidi Griesmann

2

0 references

Michaela Beitzinger

3

0 references

Lars Hofmann

4

0 references

Rasa Beinoraviciute-Kellner

5

0 references

Nicole Hüttinger-Kirchhof

7

0 references

Claudia Oswald

8

0 references

Stefan Gattenlöhner

10

0 references

Christof Burek

Regulation of muscle regulatory factors by DNA-binding, interacting proteins, and post-transcriptional modifications

11

0 references

language of work or name

English

0 references

publication date

October 2006

0 references

published in

Cancer Cell

0 references

volume

10

0 references

issue

4

0 references

page(s)

281-93

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

Overexpression of insulin-like growth factor-II induces accelerated myoblast differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

p53 in embryonic development: maintaining a fine balance

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

New antibodies recognizing p73: comparison with commercial antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

p57Kip2 is induced by MyoD through a p73-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

Dynamic gene expression during the onset of myoblast differentiation in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

Chemosensitivity linked to p73 function

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

p63 is a p53 homologue required for limb and epidermal morphogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

Role for the p53 homologue p73 in E2F-1-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

A common polymorphism acts as an intragenic modifier of mutant p53 behaviour

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

Role of the p53-homologue p73 in E2F1-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

Increased DeltaN-p73 expression in tumors by upregulation of the E2F1-regulated, TA-promoter-derived DeltaN'-p73 transcript

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

DeltaNp73 stabilises TAp73 proteins but compromises their function due to inhibitory hetero-oligomer formation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

Deregulated expression of DeltaNp73alpha causes early embryonic lethality.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

The p53 family inhibitor DeltaNp73 interferes with multiple developmental programs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

Rhabdomyosarcoma--working out the pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

p53 induces the expression of its antagonist p73 Delta N, establishing an autoregulatory feedback loop

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

Induction of p57(KIP2) expression by p73beta.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

p53 regulates myogenesis by triggering the differentiation activity of pRb.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

Plasticity of the differentiated state

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

Quantitative TP73 transcript analysis in hepatocellular carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021

Regulation of the cyclin-dependent kinase inhibitor p57Kip2 expression by p63.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2006.08.024

7 January 2021